Bank Of Montreal Clovis Oncology, Inc. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.05 - $2.85 $127,715 - $346,656	-121,634 Reduced 52.12%	111,750 $136,000
Q2 2022 Aug 11, 2022	BUY	$0.63 - $2.96 $129,180 - $606,942	205,048 Added 723.63%	233,384 $399,000
Q1 2022 May 12, 2022	BUY	$1.43 - $3.14 $40,520 - $88,975	28,336 New	28,336 $48,000
Q3 2021 Nov 12, 2021	SELL	$4.06 - $5.8 $19,459 - $27,799	-4,793 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.02 - $7.05 $24,060 - $33,790	4,793 New	4,793 $30,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.